• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

InSphero AG

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, with subsidiaries in the USA and in Germany, currently counts all of the top ten global pharmaceutical and cosmetics companies as customers. InSphero 3D Insight™ Microtissues enable more biologically relevant in vitro applications in efficacy and toxicology. The spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich has been recognized for its scientific and commercial achievements with a number of national and international awards and is also certified to the ISO 9001:2008 standard for its Quality Management System. *

 

	Start	2009-01-01 splitoff
	Group	InSphero (Group)
	Industry	cell-based assay (research)
	Person	Lichtenberg, Jan (InSphero 201401 CEO + Co-founder)
	Region	Schlieren ZH
	Country	Switzerland
	Street	27 Wagistr.
	City	8952 Schlieren ZH
	Tel	+41-44-515049-0
		Address record changed: 2020-12-02
Basic data	Employees	A: 1 to 10 (2011-04-28)
		* Document for �About Section�:
		Record changed: 2020-06-12

Advertisement

More documents for InSphero (Group)

• [1] InSphero AG. (3/27/17). "Press Release: InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing". Schlieren....
• [2] InSphero AG. (3/16/17). "Press Release: InSphero Launches 3D InSight Monkey Liver Microtissues at Annual Society of Toxicology Meeting". Schlieren....
• [3] InSphero AG. (2/2/17). "Press Release: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017". Schlieren....
• [4] InSphero AG. (11/3/16). "Press Release: InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System". Schlieren....
• [5] InSphero AG. (10/20/16). "Press Release: 3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference". Schlieren....
• [6] InSphero AG. (3/16/16). "Press Release: InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury". Schlieren....
• [7] InSphero AG. (2/1/16). "Press Release: InSphero Inc. Streamlines 3D Microtissue Business Operations in US". Schlieren....
• [8] InSphero AG. (1/21/16). "Press Release: InSphero Adds Head of Sales, Expands Global Sales Team". Schlieren....
• [9] InSphero AG. (10/15/15). "Press Release: InSphero Adds Chief Financial Officer to Senior Management Team". Schlieren....
• [10] InSphero AG. (7/8/15). "Press Release: InSphero AG Secures CHF 20 Million Series C Financing". Schlieren....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.